PATENT CLAIM ANALYSIS

Application Number: 15995471
Application Type: Utility
Filing Date: 2018-06
Publication Date: 2019-04
Patent Classification: ["424", "205100"]

Abstract:
Recombinant herpes simplex virus 2 (HSV-2) vaccine vectors, virions thereof, compositions and vaccines comprising such, and methods of use thereof are each provided.

Claim (Index 63):
A method of eliciting an immune response in a first subject against an HSV-2 and/or HSV-1 infection, comprising effectuating passive transfer to the first subject of an amount of a product from a second subject immunized with HSV-2 having a deletion of the entire HSV-2 glycoprotein D-encoding gene in the genome thereof and wherein said HSV-2 is phenotypically complemented with a herpes simplex virus-1 (HSV-1) glycoprotein D by propagating said HSV-2 in a complementing cell expressing said HSV-1 glycoprotein D, wherein the product comprises antibodies induced thereby, effective to elicit an immune response against an HSV-2 and/or HSV-1 infection in the first subject.

Metadata:
- Claim Count in Document: 11.0
- Percentile: 94.0
- Lexical Diversity: 1.16
- Patent Class: 424.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['15015322', '15455495', '13260835', '14572004', '12415152']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7008858680619025
- 35 USC 102 Novelty (BERT): 0.64063363403114
- Combined Prediction Score: 0.6948606446588262
- Mean Citation Score: 446.009292
- Max Citation Score: 587.87195
- Similarity Product: 574.5382173274577

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test